INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
Yakira Capital Management, Inc. 110,892$2,055,9380.56%
Crystalline Management Inc. 37,177$689,2620.50%
BOOTHBAY FUND MANAGEMENT, LLC 848,800$15,736,7520.37%
Leucadia National 2,000,000$37,080,0000.33%
TOKIO MARINE ASSET MANAGEMENT CO LTD 260,300$4,825,9620.31%
GABELLI & Co INVESTMENT ADVISERS, INC. 96,250$1,784,4750.29%
Virtus ETF Advisers LLC 25,272$468,5430.28%
PenderFund Capital Management Ltd. 34,840$8770.26%
HARVEST MANAGEMENT LLC 26,200$485,7480.25%
Alpine Global Management, LLC 44,660$827,9960.21%
External links

This page lists INTERCEPT PHARMACEUTICALS IN's shareholders in Q3 2023. To view INTERCEPT PHARMACEUTICALS IN's shareholder history, click here.